Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

5.210 +0.010 (+0.19%)

Streaming Delayed Price Updated: 9:33 AM EDT, Sep 1, 2026 Add to My Watchlist

Price and Volume

Volume	30,742
Open	5.180
Bid (Size)	5.150 (300)
Ask (Size)	5.220 (300)
Prev. Close	5.200
Today's Range	5.130 - 5.210
52wk Range	3.710 - 8.740
Shares Outstanding	14,508,063
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

UNCY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Unicycive Therapeutics, Inc.

July 10, 2026

From Kirby McInerney LLP

Via GlobeNewswire

UNCY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Unicycive Therapeutics, Inc.

July 08, 2026

From Kirby McInerney LLP

Via Business Wire

Performance

YTD	-10.2%	-10.2%
1 Month	+3.1%	+3.1%
3 Month	-31.4%	-31.4%
6 Month	-25.5%	-25.5%
1 Year	+20.6%	+20.6%

More News

Securities Fraud Investigation Into Unicycive Therapeutics, Inc. (UNCY) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

July 08, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

July 08, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Unicycive Therapeutics, Inc. (UNCY) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

July 07, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

UNCY SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

July 06, 2026

From Kirby McInerney LLP

Via GlobeNewswire

Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. on Behalf of Unicycive Stockholders and Encourages Investors to Contact the Firm

July 02, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

UNICYCIVE THERAPEUTICS, INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

July 01, 2026

From Kirby McInerney LLP

Via Business Wire

Wondering what's happening in today's after-hours session? ↗

July 01, 2026

Via Chartmill

Here are the top movers in Tuesday's session. ↗

June 30, 2026

Via Chartmill

Top movers analysis in the middle of the day on 2026-06-30: top gainers and losers in today's session. ↗

June 30, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

June 30, 2026

Via Chartmill

Tuesday's pre-market session: top gainers and losers ↗

June 30, 2026

Via Chartmill

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on

March 18, 2026

From Grabar Law Office

Via GlobeNewswire

Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

March 16, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Integer Holdings Corp. (NYSE: ITGR): Molina Healthcare, Inc. (NYSE: MOH); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on

March 12, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Boston Scientific Corporation (NYSE: BSX): Corcept Therapeutics, Inc. (NASDAQ: CORT); Nektar Therapeutics (NASDAQ: NKTR): and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims

March 10, 2026

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your

March 05, 2026

From Grabar Law Office

Via GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

December 18, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); Synopsys, Inc. (NASDAQ: SNPS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

December 03, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims

December 02, 2025

From Grabar Law Office

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Maison Solutions Inc. (NASDAQ: MSS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

November 14, 2025

From Grabar Law Office

Via GlobeNewswire

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

November 13, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

November 10, 2025

From Grabar Law Office

Via GlobeNewswire

UNICYCIVE ALERT: Bragar Eagel & Squire, P.C. is Investigating Unicycive Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

October 31, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Frequently Asked Questions

Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?

Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?

Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?

The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market

What is the current price of Unicycive Therapeutics, Inc. - Common Stock?

The current price of Unicycive Therapeutics, Inc. - Common Stock is 5.210

When was Unicycive Therapeutics, Inc. - Common Stock last traded?

The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 09/01/26 09:33 AM ET

What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?

The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 75.59M

How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?

Unicycive Therapeutics, Inc. - Common Stock has 76M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.